Total Funding
4
Total FundingSeries A raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.
Kenneth L. Harris: President & CEOPast Role: TotipotentRx, Founder, Chairman & CEO
About the Company
Bell Biosystems is a biotechnology company based in Berkeley, CA, and focused on developing tools for the tracking and imaging of cellular therapies. Bell combines expertise in stem cell research, cell biology, biomedical imaging, molecular biology and clinical regenerative medicine. Our vision is to create tools that accelerate the
"bench-to-bedside" progress of innovations in cell therapy pre-clinical and clinical delivery and tracking of transplanted cells.
